Pronounced clinical responses have been achieved in CD19+ large B cell lymphoma, acute lymphoblastic leukemia (ALL), and chronic lymphocytic leukemia (CLL).1 The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.